American Kidney Fund
American Kidney Fund Launches Educational Awareness Campaigns for Two Rare Kidney Diseases
26 sept. 2023 09h18 HE | American Kidney Fund
ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) launched educational awareness campaigns for two rare kidney diseases: complement 3 glomerulopathy (C3G) and...
eledon-logo-1230.png
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
20 sept. 2023 16h05 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, and Steve...
American Kidney Fund
American Kidney Fund, Home Dialyzors United Partner to Host Second Annual Dialysis at Home Summit
12 sept. 2023 10h24 HE | American Kidney Fund
ROCKVILLE, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has partnered with Home Dialyzors United, a nonprofit advocating on behalf of the home dialyzor community, to host...
eledon-logo-1230.png
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
11 sept. 2023 07h00 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the appointment of James Robinson to its Board of Directors effective...
22157.jpg
Diverse Segmentation Shapes Global Artificial Kidney Market: Device Types, Dialysis Methods, and End-Users Influence Growth Trends
11 sept. 2023 05h48 HE | Research and Markets
Dublin, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The "Global Artificial Kidney Market 2023-2030" report has been added to ResearchAndMarkets.com's offering. The global artificial kidney market is set...
Travere Therapeutics
Travere Therapeutics Joins American Kidney Fund’s 2023 Corporate Membership Program at ‘Champion’ Level
08 sept. 2023 09h51 HE | American Kidney Fund
ROCKVILLE, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Travere Therapeutics has joined the 2023 class in AKF’s Corporate Membership Program as a...
TIP_link_300x300.jpg
Organ Preservation Solution Market worth $399.49 Billion by 2028 - Exclusive Report by The Insight Partners
08 sept. 2023 06h48 HE | The Insight Partners
Pune, India, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Organ preservation solutions are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed...
Amgen Joins American
Amgen Joins American Kidney Fund’s 2023 Corporate Membership Program at ‘Champion’ Level
06 sept. 2023 09h10 HE | American Kidney Fund
ROCKVILLE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today expressed its appreciation for Amgen’s participation in the 2023 class of its Corporate Membership Program as...
eledon-logo-1230.png
Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates
06 sept. 2023 07h00 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the publication of a study evaluating tegoprubart as an immunomodulatory...
eledon-logo-1230.png
Eledon Pharmaceuticals Announces First Participant Dosed in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Rejection in Kidney Transplantation
05 sept. 2023 07h00 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the first participant has been dosed in the Company’s Phase 2 BESTOW trial...